🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Sponsor trial record
Trackers Companies Trial finder
Sponsor · clinical trials

Fujian Maternity and Child Health Hospital clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our China register with Fujian Maternity and Child Health Hospital as lead sponsor. Synced 26 Sep 2026
4Current trials
2Recruiting now
0Drugs in these trials
1Trial register
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from ClinicalTrials.gov and CTIS registry records · Last verified · Editorial standards
At a glance

Fujian Maternity and Child Health Hospital is the lead sponsor of 4 current clinical trials in our China register. 2 are recruiting patients now. All registered phases are Observational. The most-studied condition is HPV Infection.

ClinicalTrials.gov trials by status

  • Recruiting250%
  • Not yet open125%
  • Active, closed125%

Trials by phase

  • Observational4100%
01

Clinical trials sponsored by Fujian Maternity and Child Health Hospital

4 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Effect of HPV Integration on Prognosis of Young Women With CIN2 in China
NCT05282095 · ClinicalTrials.gov ↗ · Cervical Intraepithelial Neoplasia, HPV Infection, Virus Integration
Observational Recruiting 2022-06 China
Protein Molecular Characteristics and Prognosis of Cervical Neuroendocrine Tumors
NCT06276309 · ClinicalTrials.gov ↗ · Neuroendocrine Neoplasm, China, Women
Observational Recruiting 2024-02 China
Two Domestic HPV Vaccines and Imported HPV Vaccines in Women Aged 13-14 Years Study on Immunogenicity
NCT06137352 · ClinicalTrials.gov ↗ · HPV Infection, HPV Vaccine, Cervical Cancer Prevention
Observational Not yet open 2023-12 China
Characteristics of Vaginal and Intestinal Microbiota and Cervical HPV Infection
NCT05003505 · ClinicalTrials.gov ↗ · Intestinal Microbiota, Vaginal Microbiota, HPV Infection
Observational Active, closed 2021-07 China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in Fujian Maternity and Child Health Hospital trials

12 conditions
HPV Infection3Intestinal Microbiota1Vaginal Microbiota1Cervical Intraepithelial Neoplasia1Virus Integration1HSIL, High Grade Squamous Intraepithelial Lesions1HPV Vaccine1Cervical Cancer Prevention1Neuroendocrine Neoplasm1China1Women1Cervical Cancer1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in China42

A trial with sites in more than one country appears in each of those registers.

04

Other sponsors in HPV Infection

SponsorTrials
Frantz Viral Therapeutics3
Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair1

Sponsors with the most current trials registered for this condition.

05

Questions about Fujian Maternity and Child Health Hospital trials

How many clinical trials does Fujian Maternity and Child Health Hospital sponsor?

Fujian Maternity and Child Health Hospital is the lead sponsor of 4 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are Fujian Maternity and Child Health Hospital trials recruiting?

Yes. 2 of its 4 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.